Jens Pietzsch

Prof. Dr. Jens Pietzsch is the Head of the Radiopharmaceutical and Chemical Biology department at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). His research focuses on radiopharmaceutical cancer research, molecular imaging, and therapeutic targeting of cyclooxygenase (COX) pathways. His work bridges medical imaging, oncology, and pharmaceutical chemistry, with a strong emphasis on neuroendocrine tumors, melanoma, and prostate cancer.

• Institutional Affiliation: Helmholtz-Zentrum Dresden-Rossendorf (HZDR)
• Department: Radiopharmaceutical and Chemical Biology

Prof. Pietzsch's research integrates radiopharmacology, bioinorganic chemistry, and biomaterials. Key areas include:

• Development of COX-2 inhibitors as anti-cancer agents
• Radiolabeled peptides for PET/SPECT imaging
• Design of theranostic radionuclide pairs (e.g., 133La/225Ac)
• Investigation of macrophage-tumor interactions in glioma progression

His recent publications (2024-2026) highlight trends in carborane-based drug analogs, NO-releasing therapeutics, and multimodal imaging for tumor targeting. Articles emphasize PSMA ligands, Eph receptor imaging, and biomaterial platforms for cancer modeling.